Cybin Inc (CYBN)
7.49
-0.16
(-2.09%)
USD |
NYAM |
Mar 18, 15:25
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 157.49M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -56.24% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | -- |
Price to Book Value | 0.9408 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | -- |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 94.06% |
Profile
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. |
URL | https://www.cybin.com |
Investor Relations URL | N/A |
HQ State/Province | Ontario |
Sector | Health Care |
Industry | Pharmaceuticals |
Next Earnings Release | Jun. 26, 2025 (est.) |
Last Earnings Release | Feb. 10, 2025 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. |
URL | https://www.cybin.com |
Investor Relations URL | N/A |
HQ State/Province | Ontario |
Sector | Health Care |
Industry | Pharmaceuticals |
Next Earnings Release | Jun. 26, 2025 (est.) |
Last Earnings Release | Feb. 10, 2025 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |